Release details

2018-05-28 18:00 CEST
  • Print
  • Share Share
en fr

PHARMAGEST INTERACTIVE : General meeting - Preliminary notice

Villers-lès-Nancy, 28 May 2018 - 6:00 p.m. (CET)
PRESS RELEASE

Annual Ordinary and Extraordinary General Meeting

Preliminary Notice

PHARMAGEST INTERACTIVE hereby provides notice to shareholders of the annual ordinary and extraordinary general meeting to be held on Thursday, June 28, 2018 at 5.00 pm at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.
                                                                                                                                 
The agenda and draft resolutions have been published in the BALO legal gazette on May 21, 2018 (www.journal-officiel.gouv.fr). The BALO notice can be reviewed on the website of the company (www.pharmagest.com, Finance).

15 days prior to the meeting a convening notice to attend the meeting will be published in the BALO and in a legal gazette.

Pursuant to article R225-73-1 of the French commercial code, PHARMAGEST INTERACTIVE will publish the documents prescribed by this article on its website 21 days prior to the meeting.

The shareholders may obtain any further information by request to PHARMAGEST INTERACTIVE's headquarters located in VILLERS-LES-NANCY (54600).

About PHARMAGEST Group:

Pharmagest Group is the French pharmacy information technology leader, with a market share of more than 42% and more than 1,000 employees. The Group's strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.

To roll out this strategy, Pharmagest Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace.

These businesses are divided into four divisions: Pharmacy - Europe Solutions; Health and Social Care Facilities Solutions; e-Health Solutions and Fintech.
  


Listed on Euronext Paris(TM) - Compartment B
Indices: CAC® SMALL and CAC® All-Tradable par inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR 0012882389 - Reuters: PHA.PA - Bloomberg: - PMGI FP

For all the latest news go to www.pharmagest.com

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@lacooperativewelcoop.com

Financial Communications and Media Relations:
FIN'EXTENSO - Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr

HUG#2195625